Index of artpub/2019/pmc_31628428/

Burger, Jan A
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL : 5 years of follow-up from the phase 3 RESONATE-2 study
2019
https://ddd.uab.cat/record/226649